Aerie Pharmaceuticals, Inc. announced the appointments of Nils Hauptmann as Director of Regulatory Affairs and Pharmacovigilance, reporting to Cindy Martin, Aerie’s Vice President of Regulatory, and Tim Swan as Director of Sales and Transparency Operations, reporting to Gerry McKenzie, Aerie’s Vice President of Commercial Operations. Mr. Hauptmann will support the preparation of regulatory and clinical documents along with oversight of post-marketing pharmacovigilance and promotional activities. Mr. Hauptmann previously held related positions at Avanir Pharmaceuticals, Inc. and Fibrogen, Inc. Mr. Swan will lead the operational functions in support of teams that interact with healthcare providers and organizations. Mr. Swan previously held related positions at Allergan, Inc.